AP NEWS

Global Infectious Disease Therapeutics Market 2019-2023 with Profiles of Major Players - AbbVie, F. Hoffmann-La Roche, Gilead, Merck, and Sanofi - ResearchAndMarkets.com

January 10, 2019

DUBLIN--(BUSINESS WIRE)--Jan 10, 2019--The “Global Infectious Disease Therapeutics Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.

The infectious disease therapeutics market will register a CAGR of over 4% by 2023.

Development of novel drugs to drive growth in the market. There has been an increase in the R&D of novel drugs for the treatment of infectious diseases.

Increasing prevalence of infectious diseases

There has been an increase in the prevalence of infectious diseases due to climate variability. This is expected to be a major driver of the market growth during the forecast period.

Availability of counterfeit drugs

Counterfeit drugs are available in low-income and developing countries. These drugs are widely available because of insufficient regulations and manufacturing control.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Merck and Sanofi, the competitive environment is quite intense. Factors such as the development of novel drugs and the increase in the prevalence of infectious diseases, will provide considerable growth opportunities to infectious disease therapeutics manufactures.

AbbVie, F. Hoffmann-La Roche, Gilead, Merck, and Sanofi are some of the major companies covered in this report.

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

Market ecosystem Market characteristics Market segmentation analysis

PART 04: PIPELINE ANALYSIS

PART 05: MARKET SIZING

Market definition Market sizing 2018 Market size and forecast 2018-2023

PART 06: FIVE FORCES ANALYSIS

Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition

PART 07: MARKET SEGMENTATION BY TYPE

Market segmentation by type Comparison by type Antiviral Antibacterial Antifungal Others Market opportunity by type

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

Geographic segmentation Geographic comparison Key leading countries Market opportunity

PART 10: DRIVERS AND CHALLENGES

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

Overview Landscape disruption

PART 13: VENDOR ANALYSIS

Vendors covered Vendor classification Market positioning of vendors AbbVie F. Hoffmann-La Roche Gilead Merck Sanofi

PART 14: APPENDIX

For more information about this report visit https://www.researchandmarkets.com/research/9mqnvj/global_infectious?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190110005239/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Infectious Diseases Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 01/10/2019 04:23 AM/DISC: 01/10/2019 04:23 AM

http://www.businesswire.com/news/home/20190110005239/en

AP RADIO
Update hourly